Vise Technologies Inc. Invests $372,000 in Tenet Healthcare Corporation $THC

Vise Technologies Inc. bought a new position in Tenet Healthcare Corporation (NYSE:THC) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 2,112 shares of the company’s stock, valued at approximately $372,000.

Several other institutional investors and hedge funds also recently made changes to their positions in THC. Price T Rowe Associates Inc. MD boosted its position in Tenet Healthcare by 6.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 7,596,544 shares of the company’s stock worth $1,021,736,000 after buying an additional 463,552 shares during the period. Ameriprise Financial Inc. grew its stake in shares of Tenet Healthcare by 348.4% in the first quarter. Ameriprise Financial Inc. now owns 1,962,314 shares of the company’s stock worth $263,905,000 after purchasing an additional 1,524,642 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Tenet Healthcare by 12.2% in the first quarter. Dimensional Fund Advisors LP now owns 1,675,199 shares of the company’s stock valued at $225,297,000 after purchasing an additional 181,667 shares during the period. Nuveen LLC acquired a new position in Tenet Healthcare during the 1st quarter worth about $218,549,000. Finally, Boston Partners increased its position in Tenet Healthcare by 692.9% during the 1st quarter. Boston Partners now owns 1,162,642 shares of the company’s stock valued at $156,318,000 after purchasing an additional 1,016,010 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on THC. Royal Bank Of Canada raised their target price on Tenet Healthcare from $230.00 to $252.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Morgan Stanley set a $232.00 target price on shares of Tenet Healthcare and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Wall Street Zen upgraded shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Saturday, July 26th. The Goldman Sachs Group began coverage on Tenet Healthcare in a research note on Tuesday, October 14th. They issued a “buy” rating and a $224.00 target price for the company. Finally, Mizuho raised their price objective on Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, October 17th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $229.00.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $192.30 on Friday. The company has a market cap of $16.90 billion, a PE ratio of 13.18, a price-to-earnings-growth ratio of 0.89 and a beta of 1.53. The company has a quick ratio of 1.63, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $217.43. The business has a 50 day moving average price of $198.89 and a 200-day moving average price of $178.61.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 EPS for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The business had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.Tenet Healthcare’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tenet Healthcare news, CEO Saumya Sutaria sold 78,762 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $190.78, for a total transaction of $15,026,214.36. Following the transaction, the chief executive officer owned 368,683 shares of the company’s stock, valued at $70,337,342.74. This trade represents a 17.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Lisa Y. Foo sold 8,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $179.53, for a total value of $1,436,240.00. Following the sale, the executive vice president directly owned 20,878 shares of the company’s stock, valued at $3,748,227.34. The trade was a 27.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 134,044 shares of company stock worth $25,977,997 in the last ninety days. 0.81% of the stock is owned by corporate insiders.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.